Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Treatment of Depression With Botulinum Type A Toxin

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Seton Family of Hospitals
ClinicalTrials.gov Identifier:
NCT01392963
First received: July 8, 2011
Last updated: January 22, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2013
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
No publications provided by Seton Family of Hospitals

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):